04/10/2024 4:15 PM | Catalyst Pharmaceuticals (Issuer) Tierney David S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:23 PM | Catalyst Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2024 3:25 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
04/08/2024 1:03 PM | Catalyst Pharmaceuticals (Subject) Tierney David S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024 3:45 PM | Catalyst Pharmaceuticals (Issuer) Elsbernd Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 2:01 PM | Catalyst Pharmaceuticals (Subject) Elsbernd Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 4:01 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/28/2024 4:16 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2024 4:31 PM | Catalyst Pharmaceuticals (Subject) Flynn James E (Filed by)
| Form SC 13G/A | |
02/06/2024 4:00 PM | Catalyst Pharmaceuticals (Issuer) DENKHAUS DONALD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:01 PM | Catalyst Pharmaceuticals (Issuer) MCENANY PATRICK J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 9:09 AM | Catalyst Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024 4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:10 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 4:23 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 4:15 PM | Catalyst Pharmaceuticals (Filer)
| Form 424B5 | |
01/03/2024 4:18 PM | Catalyst Pharmaceuticals (Issuer) Kalb Michael Wayne (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/03/2024 4:18 PM | Catalyst Pharmaceuticals (Issuer) Daly Richard J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:18 PM | Catalyst Pharmaceuticals (Issuer) O'Keeffe Charles B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:19 PM | Catalyst Pharmaceuticals (Issuer) Tierney David S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:19 PM | Catalyst Pharmaceuticals (Issuer) MCENANY PATRICK J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) DENKHAUS DONALD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) MCENANY PATRICK J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Miller Steve (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) GRANDE ALICIA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) INGENITO GARY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Daly Richard J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Del Carmen Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Tierney David S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Harper Molly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Sundaram Preethi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) O'Keeffe Charles B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Elsbernd Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Harper Molly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 12:47 PM | Catalyst Pharmaceuticals (Subject) Harper Molly (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Del Carmen Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Thompson Tamar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Harper Molly (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Sundaram Preethi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) MCENANY PATRICK J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Global crypto currency reset (41 major banks signed up) (Ad) Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) DENKHAUS DONALD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Elsbernd Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) GRANDE ALICIA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) O'Keeffe Charles B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Miller Steve (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Tierney David S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) INGENITO GARY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 1:21 PM | Catalyst Pharmaceuticals (Subject) Tierney David S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 1:57 PM | Catalyst Pharmaceuticals (Subject) GRANDE ALICIA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 11:54 AM | Catalyst Pharmaceuticals (Subject) GRANDE ALICIA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) INGENITO GARY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/08/2023 3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/07/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Miller Steve (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 11:48 AM | Catalyst Pharmaceuticals (Subject) INGENITO GARY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023 3:46 PM | Catalyst Pharmaceuticals (Subject) Catalyst Pharmaceuticals (Subject) Miller Steve (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/03/2023 3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/27/2023 3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/13/2023 7:15 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
07/12/2023 3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form DEF 14A | |
06/29/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Del Carmen Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 4:00 PM | Catalyst Pharmaceuticals (Issuer) Thompson Tamar (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/30/2023 3:32 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 3:07 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023 7:43 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |